Jane Street’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.01M Buy
+906,162
New +$3.87M ﹤0.01% 4032
2026
Q1
Sell
-78,758
Closed -$398K 11783
2025
Q4
$398K Sell
78,758
-278,267
-78% -$1.29M ﹤0.01% 8205
2025
Q3
$1.24M Buy
357,025
+72,187
+25% +$271K ﹤0.01% 5863
2025
Q2
$968K Sell
284,838
-59,331
-17% -$198K ﹤0.01% 5677
2025
Q1
$1.38M Buy
344,169
+276,972
+412% +$1.44M ﹤0.01% 4977
2024
Q4
$436K Sell
67,197
-69,205
-51% -$412K ﹤0.01% 7062
2024
Q3
$756K Sell
136,402
-55,914
-29% -$317K ﹤0.01% 6451
2024
Q2
$1.07M Buy
192,316
+146,254
+318% +$878K ﹤0.01% 5630
2024
Q1
$309K Sell
46,062
-153,186
-77% -$1.21M ﹤0.01% 7516
2023
Q4
$1.82M Buy
199,248
+153,129
+332% +$964K ﹤0.01% 4497
2023
Q3
$255K Buy
+46,119
New +$370K ﹤0.01% 7307
2023
Q2
Sell
-16,227
Closed -$146K 8796
2023
Q1
$149K Sell
16,227
-32,002
-66% -$344K ﹤0.01% 8018
2022
Q4
$492K Buy
48,229
+26,469
+122% +$356K ﹤0.01% 6168
2022
Q3
$320K Buy
21,760
+1,521
+8% +$19.8K ﹤0.01% 7480
2022
Q2
$217K Sell
20,239
-57,380
-74% -$571K ﹤0.01% 8081
2022
Q1
$837K Buy
+77,619
New +$1.05M ﹤0.01% 6487

Other funds holding CTKB

Jane Street's CTKB Position: Q2 2026 in Review

Jane Street opened a new position in Cytek Biosciences (CTKB) in Q2 2026: 906,162 shares worth $4.01M. The stake represents ﹤0.01% of the portfolio and ranks #4032 among its holdings. This is a return to the name: Jane Street previously reported a position in CTKB as recently as Q4 2025.

Jane Street first reported a position in CTKB in Q1 2022 and has held it in 16 quarters since. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Jane Street held 906,162 shares of Cytek Biosciences worth $4.01M as of Q2 2026.
  • Cytek Biosciences was a new Jane Street position in Q2 2026.
  • Cytek Biosciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4032 holding.
  • Jane Street first reported a position in Cytek Biosciences in Q1 2022 and has held it in 16 quarters since.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.